Guardian molecule keeps cells on track: New perspectives for the treatment of liver cancer
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...
Mom Receives Shocking Stage 3 Colon Cancer Diagnosis at 25 — Hours Before It Nearly Turned Fatal
Chloe Wakelin says her cancer symptoms were initially dismissed as a stomach bug that she picked up at her job as a daycare ...
EurekAlert!3d
Candidate genes in canine hepatocellular carcinoma for molecular targeted therapy
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
Science Daily3d
New study offers hope to patients with advanced liver cancer, cirrhosis
Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.
Community Impact Newspaper2d
St. David’s becomes first Central Texas hospital to offer new liver cancer therapy
St. David’s Medical Center in Austin is the first hospital in Central Texas to offer histotripsy, a noninvasive ultrasound ...
A Promising Development for Millions of People With Liver Disease
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...
Monthly Prescribing Reference3d
Amezalpat Gets Fast Track Status for Hepatocellular Carcinoma
Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.